VANDETANIB | VANDETANIB | ATC L01XE12
PROTEIN KINASE INHIBITORS TYROSINE KINASE ANTINEOPLASTIC AGENTS MEDULLARY THYROID CANCER | ORAL | Cmax 1.7 MICROMOLAR (300 MILLIGRAM) VD 7450 LITER PPB 90 PERCENT Cl 13.2 LITER / HOUR (300 MILLIGRAM) HT 456 HOUR SOLUBILITY IS PRACTICALLY INSOLUBLE IN WATER WITH A VALUE OF 0.008 MILLIGRAM / MILLILITER AT 25 DEGRE CELSIUS | EGFR VEGF PROTEIN TYROSINE KINASE 6 (BRK) TIE2 EPH RECEPTORS KINASE FAMILY SRC FAMILY PDB 2IVU (CRYSTAL STRUCTURE OF PHOSPHORYLATED RET TYROSINE KINASE DOMAIN COMPLEXED WITH THE INHIBITOR ZD6474) LIGAND CODE = ZD6 (link to the list of PDB complexes) Download experimental 3D coordinates of ZD6 with added hydrogens | EPHRIN RECEPTOR INHIBITOR CHEMBL2363043 EPHRIN RECEPTOR O15197 EPHRIN TYPE-B RECEPTOR 6 HOMO SAPIENS UNCLASSIFIED | EMA ANSM (in French) Inxight Drugs Dailymed Drugs.com SIDER side effects Chemical Probes Portal ChEMBL BindingDB DrugBank |